| Trial ID: | L3274 |
| Source ID: | NCT00574639
|
| Associated Drug: |
Alprazolam
|
| Title: |
Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
|
| Acronym: |
Alp Ex
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Alprazolam|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in Epinephrine Levels, 32 weeks |
|
| Sponsor/Collaborators: |
Sponsor: University of Maryland, Baltimore | Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-07
|
| Completion Date: |
2016-06
|
| Results First Posted: |
|
| Last Update Posted: |
2019-09-12
|
| Locations: |
University of Maryland, Baltimore, Baltimore, Maryland, 21201, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00574639
|
